Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-28 Sale |
2021-02-01 4:30 pm |
Inozyme Pharma Inc. | INZY | Novo Holdings A/S 10% Owner |
375,000 | $21 | $7,875,000 | 2,194,379 (Direct) |
View |
| 2020-07-28 Purchase |
2020-07-29 5:29 pm |
Inozyme Pharma Inc. | INZY | Novo Holdings A/S 10% Owner |
375,000 | $16 | $6,000,000 | 2,569,379 (Direct) |
View |
| 2020-07-28 Purchase |
2020-07-29 06:06 am |
Inozyme Pharma Inc. | INZY | Sanofi 10% Owner |
81,250 | $16 | $1,300,000 | 520,125 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 8:53 pm |
Inozyme Pharma Inc. | INZY | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
600,000 | $16 | $9,600,000 | 1,067,884 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:33 pm |
Inozyme Pharma Inc. | INZY | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
600,000 | $16 | $9,600,000 | 2,003,653 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:30 pm |
Inozyme Pharma Inc. | INZY | Sonsini Peter W. 10% Owner |
250,000 | $16 | $4,000,000 | 2,437,689 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:29 pm |
Inozyme Pharma Inc. | INZY | SANDELL SCOTT D 10% Owner |
250,000 | $16 | $4,000,000 | 2,437,689 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:29 pm |
Inozyme Pharma Inc. | INZY | MAKOWER JOSHUA 10% Owner |
250,000 | $16 | $4,000,000 | 2,437,689 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:28 pm |
Inozyme Pharma Inc. | INZY | Makhzoumi Mohamad 10% Owner |
250,000 | $16 | $4,000,000 | 2,437,689 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:27 pm |
Inozyme Pharma Inc. | INZY | Florence Anthony A. Jr. 10% Owner |
250,000 | $16 | $4,000,000 | 2,437,689 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:26 pm |
Inozyme Pharma Inc. | INZY | BASKETT FOREST 10% Owner |
250,000 | $16 | $4,000,000 | 2,437,689 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:26 pm |
Inozyme Pharma Inc. | INZY | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC 10% Owner |
250,000 | $16 | $4,000,000 | 2,437,689 (Direct) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:20 pm |
Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
625,000 | $16 | $10,000,000 | 2,819,379 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:15 pm |
Inozyme Pharma Inc. | INZY | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd 10% Owner |
187,500 | $16 | $3,000,000 | 1,591,154 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:11 pm |
Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director 10% Owner |
187,500 | $16 | $3,000,000 | 1,591,154 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:08 pm |
Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
437,500 | $16 | $7,000,000 | 2,028,308 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-13 Option Award |
2021-01-14 4:19 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Jungles Steven J SVP, CTO |
44,315 | $0 | 44,315 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:17 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Huertas Pedro SVP, CMO |
36,074 | $0 | 36,074 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:16 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO |
51,105 | $0 | 51,105 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:15 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Basso Stephen SVP Finance (PFO) |
41,794 | $0 | 41,794 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:14 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
225,975 | $0 | 225,975 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-29 5:29 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Novo Holdings A/S 10% Owner |
18,592,979 | $0 | 2,569,379 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-29 06:06 am |
N/A N/A |
Inozyme Pharma Inc. | INZY | Sanofi 10% Owner |
3,718,595 | $0 | 520,125 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-28 8:53 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
3,964,388 | $0 | 1,067,884 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:33 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
11,893,163 | $0 | 2,003,653 (Indirect) |
View |
| 2020-07-25 Conversion |
2020-07-28 6:30 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Sonsini Peter W. 10% Owner |
4,375,378 | $0 | 2,437,689 (Indirect) |
View |
| 2020-07-25 Conversion |
2020-07-28 6:29 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | SANDELL SCOTT D 10% Owner |
4,375,378 | $0 | 2,437,689 (Indirect) |
View |
| 2020-07-25 Conversion |
2020-07-28 6:29 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | MAKOWER JOSHUA 10% Owner |
4,375,378 | $0 | 2,437,689 (Indirect) |
View |
| 2020-07-25 Conversion |
2020-07-28 6:28 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Makhzoumi Mohamad 10% Owner |
4,375,378 | $0 | 2,437,689 (Indirect) |
View |
| 2020-07-25 Conversion |
2020-07-28 6:27 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Florence Anthony A. Jr. 10% Owner |
4,375,378 | $0 | 2,437,689 (Indirect) |
View |
| 2020-07-25 Conversion |
2020-07-28 6:26 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | BASKETT FOREST 10% Owner |
4,375,378 | $0 | 2,437,689 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:26 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC 10% Owner |
2,187,689 | $0 | 2,437,689 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:20 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
18,592,979 | $0 | 2,819,379 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:15 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Jungles Steven J See Remarks |
113,381 | $0 | 55,417 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:15 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd 10% Owner |
11,893,164 | $0 | 1,591,154 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:13 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Schlessinger Joseph 10% Owner |
113,381 | $0 | 286,479 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:11 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director 10% Owner |
11,893,164 | $0 | 1,591,154 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:11 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | ALEXION PHARMACEUTICALS INC. 10% Owner |
9,404,270 | $0 | 1,109,910 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:08 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
13,478,920 | $0 | 2,028,308 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 5:06 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Mathers Edward T Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:54 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Huertas Pedro See Remarks |
43,951 | $0 | 43,951 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:50 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Treco Douglas A Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:49 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Edwards Martin Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:49 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn See Remarks |
32,905 | $0 | 32,905 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:48 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Bolte Axel See Remarks 10% Owner |
287,706 | $0 | 287,706 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:47 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:46 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | DIAZ REINALDO M Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:43 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Sullivan Lynne Marie Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:43 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Bhagat Sarah M Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:42 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Basso Stephen Senior Vice President, Finance |
27,433 | $0 | 27,433 (Direct) |
View |
Ownership |
2020-07-23 9:34 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | ALEXION PHARMACEUTICALS INC. 10% Owner |
0 | $0 | 1,109,910 (Direct) |
View |
Ownership |
2020-07-23 9:33 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director 10% Owner |
0 | $0 | 1,403,654 (Indirect) |
View |
Ownership |
2020-07-23 9:33 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Jungles Steven J See Remarks |
0 | $0 | 210,641 (Indirect) |
View |
Ownership |
2020-07-23 9:32 pm |
N/A 2028-01-07 |
Inozyme Pharma Inc. | INZY | Basso Stephen Senior Vice President, Finance |
0 | $0 | 66,905 (Direct) |
View |
Ownership |
2020-07-23 9:31 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
0 | $0 | 467,884 (Indirect) |
View |